These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2804845)

  • 1. Bioequivalence of generic aerosol bronchodilators: what are the issues?
    Spino M
    CMAJ; 1989 Nov; 141(9):883-7. PubMed ID: 2804845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special problems in aerosol delivery: neonatal and pediatric considerations.
    Cole CH
    Respir Care; 2000 Jun; 45(6):646-51. PubMed ID: 10894457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes.
    Adams WP; Poochikian G; Taylor AS; Patel RM; Burke GP; Williams RL
    J Aerosol Med; 1994; 7(2):119-34. PubMed ID: 10147277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products.
    Marzo A; Balant LP
    Arzneimittelforschung; 1995 Feb; 45(2):109-15. PubMed ID: 7710428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioequivalence studies of pharmaceutical preparations].
    Vetchý D; Frýbortová K; Rabisková M; Danecková H
    Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could interchangeable use of dry powder inhalers affect patients?
    Price D; Summers M; Zanen P
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic products of antiepileptic drugs (AEDs): is it an issue?
    Bialer M
    Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do all dry powder inhalers show the same pharmaceutical performance?
    Taylor A; Gustafsson P
    Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for submission of bioequivalence data; final rule. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jan; 74(11):2849-62. PubMed ID: 19385107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aerosol generation and delivery systems for pulmonary drug administration: theory and practice].
    Newhouse MT
    Z Gesamte Inn Med; 1993 Aug; 48(8):363-8. PubMed ID: 8379217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to aerosol therapy in management of asthma at primary care level.
    Athavale AU; More NP; More NN; Chajed P; Gandewar K; Shah AC
    J Indian Med Assoc; 1997 Jan; 95(1):12-3. PubMed ID: 9212561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Aerosol-in-bag" administration of inhaled bronchodilators.
    el-Kassimi FA
    Eur J Respir Dis; 1987 Apr; 70(4):234-8. PubMed ID: 3582520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.
    Lennernäs H; Abrahamsson B
    J Pharm Pharmacol; 2005 Mar; 57(3):273-85. PubMed ID: 15807982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases].
    Boulet LP; d'Amours P; Bérubé D; Rouleau M; Parent JG; Pelletier C; Touchette C
    Union Med Can; 1994 Jan; 123(1):23-31. PubMed ID: 8109063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy.
    Verbeeck RK; Kanfer I; Walker RB
    Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.